Joseph Vincent
Joseph Vincent Culotta, Jr., Coppell, TX US
Patent application number | Description | Published |
---|---|---|
20130107668 | CONVOY-BASED SYSTEMS AND METHODS FOR LOCATING AN ACOUSTIC SOURCE | 05-02-2013 |
Joseph Vincent Ierulli, Vancouver, WA US
Patent application number | Description | Published |
---|---|---|
20140194922 | Nasal Dilator and Methods of Fabricating Medical Devices - Methods are disclosed for converting on a mass scale elongated material webs into finished parts or devices. Slits form strands in a web, the strands comprising interconnected objects which correspond to parts of finished devices. Strands are combined with additional webs to form a material laminate from which finished devices are die cut. The methods are suitable for a range of converting applications including medical devices, particularly the external nasal dilator. Complex dilator devices produced from the methods are formed as a single body truss having horizontal regions adapted to engage outer wall tissues of first and second nasal passages of a nose. When in use the dilator stabilizes or expands nasal outer wall tissues and prevents the outer wall tissues from drawing inward during breathing. Methods of manufacture comprise separate steps for fabricating and assembling the elements and layers of finished dilator devices and for packaging finished devices individually or in groups. Waste material is incorporated into subsequent fabrication processes to produce the same or complementary devices. | 07-10-2014 |
Joseph Vincent Ierulli, Portland, OR US
Patent application number | Description | Published |
---|---|---|
20120209313 | Nasal Dilator With Means To Direct Resilient Properties - A nasal dilator comprises a laminate of vertical layers that form a unitary, or single body, truss having horizontal regions adapted to engage outer wall tissues of first and second nasal passages and to traverse the bridge of a nose therebetween. When in use the dilator acts to stabilize and/or expand the nasal outer wall tissues and prevent said tissues from drawing inward during breathing. The dilator includes multiple parallel resilient members or a resilient member having a plurality of component spring fingers extending from a common center. The dilator may further include material separations, or discontinuity of shape of material, formed in at least one region of the truss and extending through at least one layer of the dilator. | 08-16-2012 |
20140148844 | Nasal Dilator With Means To Direct Resilient Properties - A nasal dilator of vertically laminated layers, each consisting of one or more components. The laminated layers form a unitary truss with end regions for engaging outer wall tissues of a user's nasal passages and for traversing the bridge of the nose. The dilator includes means to direct its resilient properties comprising material separations or shape discontinuities formed in at least one region of the truss and extending through at least one layer of the dilator. Said material separations or discontinuities may comprise an opening, relief cut, slit or notch, and may be configured to separate or vertically protrude from the dilator when it is in use. The separations transform the angle of focused delaminating spring biasing forces generated by the resilient layer from primarily peel forces into primarily shear forces, and further redistribute the transformed forces to tissue-engaging surface areas extending outward and beyond the separations. | 05-29-2014 |
Joseph Vincent Niosi, Woodbury, NY US
Patent application number | Description | Published |
---|---|---|
20130283363 | SECURE DATA TRANSFER OVER AN ARBITRARY PUBLIC OR PRIVATE TRANSPORT - A method, system, and computer program product for transferring data between endpoint devices is provided. The method includes determining a send pattern utilizing account credentials of a user. The send pattern defines a plurality of offset and length pairs. The method further includes creating packets of data according to the send pattern. Each packet of data contains randomly assigned data of different sizes. The method also includes encrypting each packet of data to produce a set of encrypted packets of data and sending the set of encrypted packets of data to a destination endpoint device in an order determined according to the account credentials. | 10-24-2013 |
Joseph Vincent Pease, Iii, Lakewood, OH US
Patent application number | Description | Published |
---|---|---|
20110296594 | ENERGY MANAGEMENT STRUCTURE - An energy management structure is adapted to absorb a force applied thereto. The structure includes a first component possessing a first compressive response profile, a second component possessing a second compressive response profile different from the first compressive response profile, and a third component connecting the first component to the second component. Upon application of a force, the second compressive response profile of the second component is additive to the first compressive response profile of the first component to result in an overall compressive response profile of the energy management structure that meets a design compressive response profile. | 12-08-2011 |
20140318911 | ENERGY MANAGEMENT STRUCTURE - An energy management structure is adapted to absorb a force applied thereto. The structure includes a first component possessing a first compressive response profile, a second component possessing a second compressive response profile different from the first compressive response profile, and a third component connecting the first component to the second component. Upon application of a force, the second compressive response profile of the second component is additive to the first compressive response profile of the first component to result in an overall compressive response profile of the energy management structure that meets a design compressive response profile. | 10-30-2014 |
Joseph Vincent Ranalletta, Centennial, CO US
Patent application number | Description | Published |
---|---|---|
20120060966 | Automated Medical Liquid Filling System and Method - A medical liquid filling system and associated methods are provided, the system comprising a disposable and a drive system. The disposable includes a tubular member and a piston slidably disposed within the tubular member for retraction and advancement within at least a first portion of the tubular member. The disposable may include a seal member for sealing the first portion of the tubular member and may be interconnected to the piston for co-movement therewith. The drive system may include a piston drive member selectively interconnectable to the piston for driven advancement and retraction of the piston within the tubular member. The drive system may be interconnected to a controller, which may be operable to automate or semi-automate various filling operations. A user interface may be interconnected to the controller for providing input of various system operation parameters, which may be communicated to the controller to facilitate automated or semi-automated operation of the filing system. | 03-15-2012 |
20130192719 | AUTOMATED MEDICAL LIQUID FILLING SYSTEM AND METHOD - A medical liquid filling system and associated methods are provided, the system comprising a disposable and a drive system. The disposable includes a tubular member and a piston slidably disposed within the tubular member for retraction and advancement within at least a first portion of the tubular member. The disposable may include a seal member for sealing the first portion of the tubular member and may be interconnected to the piston for co-movement therewith. The drive system may include a piston drive member selectively interconnectable to the piston for driven advancement and retraction of the piston within the tubular member. The drive system may be interconnected to a controller, which may be operable to automate or semi-automate various filling operations. A user interface may be interconnected to the controller for providing input of various system operation parameters, which may be communicated to the controller to facilitate automated or semi-automated operation of the filling system. | 08-01-2013 |
Joseph Vincent Rinella, Jr., Brownsburg, IN US
Patent application number | Description | Published |
---|---|---|
20120208980 | PROCESS FOR SOLUBILIZING GLUCAGON-LIKE PEPTIDE 1 COMPOUNDS - Disclosed is a method of preparing a GLP-1 compound that is soluble in aqueous solution at pH 7.4 from a GLP-1 compound that is substantially insoluble in aqueous solution at pH 7.4. The insoluble GLP-1 compound is dissolved in aqueous base or in aqueous acid to form a GLP-1 solution. The GLP-1 solution is then neutralized to a pH at which substantially no amino acid racemization of the GLP-1 compounds occurs, after which the soluble GLP-1 compound is isolated from the neutralized solution. | 08-16-2012 |
Joseph Vincent Rinella, Jr., Ypsilanti, MI US
Patent application number | Description | Published |
---|---|---|
20110053838 | PROCESS FOR SOLUBILIZING GLUCAGON-LIKE PEPTIDE 1 COMPOUNDS - Disclosed is a method of preparing a GLP-1 compound that is soluble in aqueous solution at pH 7.4 from a GLP-1 compound that is substantially insoluble in aqueous solution at pH 7.4. The insoluble GLP-1 compound is dissolved in aqueous base or in aqueous acid to form a GLP-1 solution. The GLP-1 solution is then neutralized to a pH at which substantially no amino acid racemization of the GLP-1 compounds occurs, after which the soluble GLP-1 compound is isolated from the neutralized solution. | 03-03-2011 |
20120101034 | PROCESS FOR SOLUBILIZING GLUCAGON-LIKE PEPTIDE 1 COMPOUNDS - Disclosed is a method of preparing a GLP-1 compound that is soluble in aqueous solution at pH 7.4 from a GLP-1 compound that is substantially insoluble in aqueous solution at pH 7.4. The insoluble GLP-1 compound is dissolved in aqueous base or in aqueous acid to form a GLP-1 solution. The GLP-1 solution is then neutralized to a pH at which substantially no amino acid racemization of the GLP-1 compounds occurs, after which the soluble GLP-1 compound is isolated from the neutralized solution. | 04-26-2012 |
Joseph Vincent Rinella, Jr., Collegeville, PA US
Patent application number | Description | Published |
---|---|---|
20130072658 | PROCESS FOR SOLUBILIZING GLUCAGON-LIKE PEPTIDE 1 COMPOUNDS - Disclosed is a method of preparing a GLP-1 compound that is soluble in aqueous solution at pH 7.4 from a GLP-1 compound that is substantially insoluble in aqueous solution at pH 7.4. The insoluble GLP-1 compound is dissolved in aqueous base or in aqueous acid to form a GLP-1 solution. The GLP-1 solution is then neutralized to a pH at which substantially no amino acid racemization of the GLP-1 compounds occurs, after which the soluble GLP-1 compound is isolated from the neutralized solution. | 03-21-2013 |